Jake Cole

Supply chain exposure appears to be becoming a more consequential part of the federal cybersecurity conversation as organizations rely on expanding networks of software, cloud services, and third-party providers. Google Cloud's Cloud Threat Horizons Report H1 2026 found that third-party software vulnerabilities accounted for 44.5% of observed initial-access activity in H2 2025, compared with 2.9% in H1. The report also observed that the period between vulnerability disclosure and exploitation had contracted from weeks to days. These findings may suggest that security considerations increasingly extend across connected suppliers, SaaS environments, and software ecosystems.

Businesses often use new contracts, new clients, and rising revenue as shorthand for progress. Yet growth figures can obscure another question that is equally consequential: how much of the business already won is being retained? Research from the U.S. Bureau of Labor Statistics shows that survival rates for new business establishments vary by year, industry, and location, with economic conditions such as recessions affecting survival rates.

Global spending on artificial intelligence appears set for another major increase in 2026, with Gartner forecasting $2.59 trillion in worldwide AI spending, up 47% from the previous year. The scale of that investment may be encouraging companies to treat AI adoption as an important signal of technological readiness, sometimes creating pressure to implement tools before the underlying business case has been fully established. Gartner also notes that enterprises have so far tended to favor tactical initiatives aimed at incremental efficiency and productivity gains, while proving broader business value remains a challenge.

American healthcare is spending at a scale that makes prevention increasingly difficult to ignore. National health expenditures rose 7.2% in 2024 to $5.3 trillion, according to the Centers for Medicare & Medicaid Services. Hospital spending alone reached $1.63 trillion, while physician and clinical services accounted for another $1.11 trillion. The numbers capture the enormous resources devoted to treating illness, but they also raise a harder question: how much more value could healthcare create by helping people understand and address health risks earlier?

Criterion canonizes Mendonça Filho’s nervy, despairing, intimate film as a new classic.

Global employee engagement has fallen to its lowest level since 2020, according to Gallup's 2026 State of the Global Workplace . This transformation

Maddin runs wild channeling the spirit of the silent era across his third feature.

The U.S. Food and Drug Administration describes drug development as a process that moves from discovery and laboratory research through preclinical testing, human clinical trials, regulatory review, and post-market monitoring. That reality may create a difficult tension for biotechnology. The scientific process often requires experimentation, iteration, and learning from failure. However, the financial system supporting early-stage companies may demand visible return on investment within a relatively short time.

U.S. school systems face funding and workforce pressures as leaders focus on building internal capacity for lasting improvement.

Behind every property, there are often countless decisions, documents, and conversations that AI is beginning to influence. A recent report from Deloitte indicates that AI is moving into real estate workflows. The debate often begins with jobs. A more practical starting point may be the work itself. Which tasks can technology support, and which responsibilities still require human judgment? For property managers, that distinction may matter because a building is a financial asset and a place shaped by owners, tenants, vendors, visitors, and communities.